Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of normal human immunoglobulins in pediatric toxic shock
2013-005509-29Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Countries
- 1
01
Overview
Phase 2, randomised trial in toxic shock syndrome (TSS) comparing Privigen plus standard of care with Standard of care alone (2 arms). Primary endpoint: Feasibility of randomized controlled trial of normal human immunoglobulins in pediatric toxic shock. Started Jun 2015; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
toxic shock syndrome (TSS)
Beyond the preview
Go deeper on 2013-005509-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005509-29.